「Real‑world treatment outcomes among patients with metastatic pancreatic cancer in Japan: The Tokushukai real‑world data project」の関連論文
-
Docetaxel plus cisplatin in recurrent and/or metastatic non-squamous-cell head and neck cancer: a multicenter phase II trial
-
Multicenter phase II study of trifluridine/tipiracil for esophageal squamous carcinoma refractory/intolerant to 5-fluorouracil, platinum compounds, and taxanes: the ECTAS study
-
転移性尿路上皮癌に対するGC療法における, Gemcitabine投与後の発熱の臨床的意義の検討: 多施設共同後ろ向き研究
-
Stereotactic body radiotherapy for primary non-small cell lung cancer patients with clinical T3-4N0M0 (UICC 8th edition): outcomes and patterns of failure
-
Modified Glasgow prognostic score is a pre-surgical prognostic marker of disease mortality in upper urinary tract urothelial carcinoma
-
Efficacy and safety of S-1 following gemcitabine with cisplatin for advanced biliary tract cancer
-
Efficacy and safety of neoadjuvant chemoradiation therapy administered for 5 versus 2 weeks for resectable and borderline resectable pancreatic cancer
-
Clinical outcomes of neoadjuvant chemotherapy for patients with breast cancer: Tri-weekly nanoparticle albumin-bound paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide: a retrospective observational study.
-
Chemotherapy for biliary tract cancer: real-world experience in a single institute
-
Drug-induced interstitial lung disease after chemoimmunotherapy for extensive-stage small cell lung cancer
-
Impact of thoracic esophageal displacement after lobectomy on the continuity of oral adjuvant chemotherapy.
-
Efficacy of local therapy for oligoprogressive disease after programmed cell death 1 blockade in advanced non-small cell lung cancer
-
Very Early Recurrence After Liver Resection for Intrahepatic Cholangiocarcinoma Considering Alternative Treatment Approaches
-
PTEN is a predictive biomarker of trastuzumab resistance and prognostic factor in HER2-overexpressing gastroesophageal adenocarcinoma
-
Combination therapy of capecitabine, irinotecan, oxaliplatin, and bevacizumab as a first‐line treatment for metastatic colorectal cancer : Safety lead‐in results from the QUATTRO-II study
-
The efficacy of oxaliplatin combination adjuvant chemotherapy for elderly patients with stage III colorectal cancer
-
Serum IgG level is a predicting factor for the response to neoadjuvant chemotherapy in patients with esophageal squamous cell carcinoma
-
Comparison of efficacy and safety outcomes of anticancer drugs between Japanese patients and the overall population in multi-regional clinical trials
-
Placental growth factor is a predictive biomarker for ramucirumab treatment in advanced gastric cancer
-
Controlling lymph node micrometastases by neoadjuvant chemotherapy affects the prognosis in advanced esophageal squamous cell carcinoma
-
Neutrophil–lymphocyte Ratio and Histological Response Correlate With Prognosis of Gastric Cancer Undergoing Neoadjuvant Chemotherapy
-
分子標的薬時代における転移性腎癌の腫瘍縮小率が予後に与える影響
-
Helical tomotherapy for asymptomatic chemotherapy-refractory or -unfit multiple (3 or more) metastases
-
Factors associated with the response to atezolizumab/bevacizumab combination therapy for hepatocellular carcinoma
-
FOLFIRINOX as first-line chemotherapy in Japanese patients suffering from metastatic pancreatic cancer (KOBE FOLFIRINOX Study)
-
Preoperative neutrophil-to-lymphocyte ratio predicts the prognosis of esophageal squamous cell cancer patients undergoing minimally invasive esophagectomy after neoadjuvant chemotherapy
-
The impact of contour maps on estimating the risk of gastrointestinal stromal tumor recurrence: indications for adjuvant therapy: an analysis of the Kinki GIST registry
-
Utility of plasma circulating tumor DNA and tumor DNA profiles in head and neck squamous cell carcinoma
-
Comparable efficacy and safety of COVID-19 vaccines for patients receiving tegafur–uracil as postoperative adjuvant chemotherapy
-
Kinetic information from dynamic contrast-enhanced MRI enables prediction of residual cancer burden and prognosis in triple-negative breast cancer,a retrospective study
-
Comparison of cytoreductive surgery and resection of isolated peritoneal metastases in patients with peritoneal metastases from colorectal cancer: a retrospective study
-
Efficacy and safety of apalutamide in patients with metastatic castration-resistant prostate cancer (GENESIS): protocol for a multicentre, open-label, single-arm clinical trial
-
The Elevation in Preoperative Procalcitonin Is Associated with a Poor Prognosis for Patients Undergoing Resection for Colorectal Cancer.
-
Proton radiotherapy as a treatment strategy to increase survival in locally advanced pancreatic cancer in the body and tail: a retrospective study
-
Outcomes of palliative surgery for bone metastasis of metastatic renal cell carcinoma in the era of targeted therapy
-
MYC Upregulation Is a Useful Biomarker for Preoperative Neoadjuvant Chemotherapy Combined With Anti-EGFR in Liver Metastasis from Colorectal Cancer
-
外科的に切除された膵癌におけるST2発現の臨床病理学的及び予後との関連性の検討
-
A High C-Reactive Protein Level on Postoperative Day 7 is Associated with Poor Survival of Patients with Pancreatic Ductal Adenocarcinoma after Resection.
-
The baseline recurrence risk of patients with intermediate-risk cervical cancer.
-
Outcomes of the Sequential Treatment of Unresectable Hepatocellular Carcinoma Using Lenvatinib
-
Solitary fibrous tumor/hemangiopericytoma treated with temozolomide plus bevacizumab: a report of four cases and literature review
-
Impact of age on clinicopathological features and survival of epithelial ovarian neoplasms in reproductive age
-
Impact of maintenance of postoperative performance status on survival in elderly patients over 70 with high-grade astrocytoma
-
腎移植後に発生した悪性腫瘍の臨床的検討
-
The Combination of Prognostic Nutritional Indicator and Serum Carcinoembryonic Antigen is Useful in Predicting Postoperative Recurrence in Stage II Colorectal Cancer
-
Apixaban in Japanese patients with cancer-associated venous thromboembolism: a multi-center phase II trial
-
Clinical outcomes of low-dose-rate brachytherapy based radiotherapy for intermediate risk prostate cancer.
-
Avelumab plus Axitinib for the Treatment of Patients with End-Stage Renal Disease Undergoing Dialysis: A Retrospective Case Series and Literature Review
-
Systemic Opioids for Dyspnea in Cancer Patients: A Real-world Observational Study
-
Effect of Radiotherapy after Breast-conserving Surgery in Elderly Patients with Early Breast Cancer according to the American Joint Committee on Cancer 8th Edition Breast Cancer Staging System in Japan